publicações selecionadas artigo académico Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c] thiazoles: the search for selective p53-activating agents for colorectal cancer therapy. RSC Medicinal Chemistry. 2024 documento "New Chiral 6,7- Bis(hydroximethyl)-1H,3H-pyrrolo[1,2-c] thiazoles as p-53 Activating Agents for Colorectal Cancer Targeted Therapy" 2023 Apresentação do Poster: "Chiral 6,7-Bis (hydroxymethyl)-1H,3H-pyrrolo[1,2-c] thiazoles: New p53 Protein Activating Agents for Colorectal Cancer Therapy" 2022 teses Síntese de Novos Derivados 6,7-Bis(hidroximetil)-1H,3H-Pirrolo[1,2-C]tiazóis Quirais como Ativadores da Proteína p53para o Tratamento do Cancro Colorretal 2023
